Gaush Meditech Ltd (FRA:F7Y)

Gaush Meditech Statistics

Total Valuation

Gaush Meditech has a market cap or net worth of EUR 137.10 million. The enterprise value is 148.90 million.

Market Cap	137.10M
Enterprise Value	148.90M

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Current Share Class	145.33M
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-1.13%
Owned by Insiders (%)	44.51%
Owned by Institutions (%)	0.97%
Float	50.06M

Valuation Ratios

The trailing PE ratio is 11.32.

PE Ratio	11.32
Forward PE	n/a
PS Ratio	0.80
PB Ratio	0.69
P/TBV Ratio	3.30
P/FCF Ratio	9.22
P/OCF Ratio	8.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.94, with an EV/FCF ratio of 10.01.

EV / Earnings	12.29
EV / Sales	0.85
EV / EBITDA	4.94
EV / EBIT	7.46
EV / FCF	10.01

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.28.

Current Ratio	2.40
Quick Ratio	1.28
Debt / Equity	0.28
Debt / EBITDA	1.89
Debt / FCF	3.75
Interest Coverage	6.16

Financial Efficiency

Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 4.75%.

Return on Equity (ROE)	6.03%
Return on Assets (ROA)	3.81%
Return on Invested Capital (ROIC)	4.75%
Return on Capital Employed (ROCE)	7.68%
Revenue Per Employee	208,907
Profits Per Employee	14,788
Employee Count	884
Asset Turnover	0.54
Inventory Turnover	2.11

Taxes

In the past 12 months, Gaush Meditech has paid 7.94 million in taxes.

Income Tax	7.94M
Effective Tax Rate	40.65%

Stock Price Statistics

The stock price has decreased by -11.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.65%
50-Day Moving Average	0.94
200-Day Moving Average	0.83
Relative Strength Index (RSI)	39.67
Average Volume (20 Days)	233

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gaush Meditech had revenue of EUR 171.09 million and earned 12.11 million in profits. Earnings per share was 0.08.

Revenue	171.09M
Gross Profit	79.79M
Operating Income	19.52M
Pretax Income	19.52M
Net Income	12.11M
EBITDA	26.75M
EBIT	19.52M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 45.60 million in cash and 55.75 million in debt, giving a net cash position of -10.15 million.

Cash & Cash Equivalents	45.60M
Total Debt	55.75M
Net Cash	-10.15M
Net Cash Per Share	n/a
Equity (Book Value)	199.12M
Book Value Per Share	1.36
Working Capital	72.39M

Cash Flow

In the last 12 months, operating cash flow was 16.94 million and capital expenditures -2.07 million, giving a free cash flow of 14.88 million.

Operating Cash Flow	16.94M
Capital Expenditures	-2.07M
Free Cash Flow	14.88M
FCF Per Share	n/a

Margins

Gross margin is 46.63%, with operating and profit margins of 11.41% and 7.08%.

Gross Margin	46.63%
Operating Margin	11.41%
Pretax Margin	11.41%
Profit Margin	7.08%
EBITDA Margin	15.64%
EBIT Margin	11.41%
FCF Margin	8.69%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.37%.

Dividend Per Share	0.03
Dividend Yield	3.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	145.79%
Buyback Yield	0.77%
Shareholder Yield	4.14%
Earnings Yield	8.83%
FCF Yield	10.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gaush Meditech has an Altman Z-Score of 2.74 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.74
Piotroski F-Score	8